Piper Sandler Maintains Overweight on Exact Sciences, Raises Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg has maintained an Overweight rating on Exact Sciences (NASDAQ:EXAS) and raised the price target from $75 to $85.
September 12, 2024 | 10:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has maintained an Overweight rating on Exact Sciences and increased the price target from $75 to $85, indicating a positive outlook.
The increase in price target from $75 to $85 by Piper Sandler suggests a positive outlook for Exact Sciences, likely leading to a short-term price increase. The Overweight rating indicates confidence in the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100